Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)

Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)

Bibliographic Details
Main Authors: A. Necchi, D. Raggi, M. Bandini, E. Farè, P. Giannatempo, M. Colecchia, F. Pederzoli, A. Gallina, L. Marandino, G. Calareso, R. Madison, A. Briganti, J. Ross, F. Montorsi
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320336508

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320336508

Similar Items